Maximum Dose of Tizanidine
The maximum recommended total daily dose of tizanidine is 36 mg per day, typically divided into three doses, with individual doses not exceeding 12 mg 1.
Dosing Framework
The FDA-approved dosing parameters for tizanidine are clearly defined:
- Starting dose: 2-4 mg, typically given up to three times daily 2, 1
- Titration: Increase gradually in 2-4 mg increments at intervals of 3-7 days 1
- Maximum single dose: 8-12 mg (though experience with single doses exceeding 8 mg is limited) 1
- Maximum total daily dose: 36 mg per 24 hours 1
- Dosing interval: Every 6-8 hours, up to three times daily 1
Evidence Base for Maximum Dosing
The 36 mg/day ceiling is established through multiple clinical trials demonstrating both efficacy and safety limits:
- In spinal cord injury patients, the effective dose range was 24-36 mg/day given in three divided doses, achieving 20% mean reduction in muscle tone 3
- In stroke-related spasticity, only 10 of 47 patients (21%) were able to reach the maximum 36 mg daily dose, with a mean effective dose of 23 mg/day 4
- For neuropathic pain, the mean effective or maximum tolerated dose was 23 mg/day (range 6-36 mg/day) 5
The Physician's Desk Reference explicitly states that experience with repeated single daytime doses greater than 12 mg or total daily doses greater than 36 mg is essentially nonexistent 1.
Special Population Considerations
Older Adults
Older persons rarely tolerate doses greater than 30-40 mg per day 2. This is critical because:
- Clearance is decreased four-fold in elderly patients 1
- Higher risk of sedation, orthostasis, and cognitive effects 2
- Recent evidence shows baclofen carries higher risk of injury (HR=1.54) and delirium (HR=3.33) compared to tizanidine in older adults, making tizanidine the preferred muscle relaxant in this population 6
Hepatic/Renal Impairment
While the initial dose should not be modified 7, extreme caution is warranted as tizanidine clearance may be significantly reduced. The maximum dose should likely be lower than 36 mg/day in these patients, though specific guidance is not provided in the evidence.
Critical Safety Warnings
Do not exceed 36 mg per day under any circumstances. The evidence base beyond this dose is absent, and several safety concerns emerge:
- Hepatotoxicity: One patient developed significant liver function test elevations with symptoms at week 4 of treatment 5
- QT prolongation: Tizanidine blocks IKr and can prolong the QT interval, with maximal QTc prolongation of ~12 ms observed 8
- Sedation: The most common dose-limiting adverse effect, occurring in 25-62% of patients 4, 9
- Hypotension and orthostasis: Particularly problematic in older adults 2
Common Pitfalls to Avoid
Food effects: Tizanidine pharmacokinetics are significantly altered by food. Switching between fed and fasted states can result in increased adverse events or altered onset of activity 1. Maintain consistent administration relative to meals.
Drug interactions:
Abrupt discontinuation: Avoid sudden cessation due to risk of CNS irritability 2
Timing of assessment: Effects peak at 1-2 hours and dissipate between 3-6 hours 1. Assess muscle tone at appropriate intervals relative to dosing.